BACKGROUND: Necrotizing enterocolitis (NEC) is a major cause of death and morbidity in very low birth weight infants. OBJECTIVE: To identify biomarker(s) that would predict NEC using buccal swab samples utilizing a proteomic approach. METHODS: Cumulative buccal swab samples derived from very low birth weight preterm infants (<32 weeks' gestational age and <1,250 g) at 1, 2 and 3 weeks prior to the development of NEC and matched controls were subjected to two-dimensional difference gel electrophoresis and LC-MS/MS analysis for proteomic protein discovery. After identification of 21 altered proteins, we chose 3 candidate proteins using a broad systems biologic analysis approach that suggested several altered cellular processes that could be associated with NEC. RESULTS: Preliminary validation studies using Western blots on these samples and 10 additional NEC and 10 matched control buccal samples collected within 2 or 3 weeks before NEC diagnosis analysis showed lower interleukin-1 receptor antagonist. CONCLUSION: Our results suggest that interleukin-1 receptor antagonist is worthy of further studies to determine its utility in helping predict NEC.
BACKGROUND:Necrotizing enterocolitis (NEC) is a major cause of death and morbidity in very low birth weight infants. OBJECTIVE: To identify biomarker(s) that would predict NEC using buccal swab samples utilizing a proteomic approach. METHODS: Cumulative buccal swab samples derived from very low birth weight preterm infants (<32 weeks' gestational age and <1,250 g) at 1, 2 and 3 weeks prior to the development of NEC and matched controls were subjected to two-dimensional difference gel electrophoresis and LC-MS/MS analysis for proteomic protein discovery. After identification of 21 altered proteins, we chose 3 candidate proteins using a broad systems biologic analysis approach that suggested several altered cellular processes that could be associated with NEC. RESULTS: Preliminary validation studies using Western blots on these samples and 10 additional NEC and 10 matched control buccal samples collected within 2 or 3 weeks before NEC diagnosis analysis showed lower interleukin-1 receptor antagonist. CONCLUSION: Our results suggest that interleukin-1 receptor antagonist is worthy of further studies to determine its utility in helping predict NEC.
Authors: Pingping Jiang; Per T Sangild; Richard H Siggers; Wai-Hung Sit; Cheuk-Lun Lee; Jennifer Man-Fan Wan Journal: Neonatology Date: 2010-12-04 Impact factor: 4.035
Authors: Jason M Low; Anil K Chauhan; David S Gibson; Mengmeng Zhu; Sixue Chen; Madeleine E Rooney; Michael J Ombrello; Terry L Moore Journal: Proteomics Clin Appl Date: 2009-07 Impact factor: 3.494
Authors: Els R Van Haver; Per T Sangild; Marijke Oste; Jayda L A Siggers; Andre L M Weyns; Christa J Van Ginneken Journal: J Pediatr Gastroenterol Nutr Date: 2009-07 Impact factor: 2.839
Authors: Erika C Claud; Lei Lu; Pauline M Anton; Tor Savidge; W Allan Walker; Bobby J Cherayil Journal: Proc Natl Acad Sci U S A Date: 2004-04-27 Impact factor: 11.205
Authors: Natasha Letunica; Tengyi Cai; Jeanie L Y Cheong; Lex W Doyle; Paul Monagle; Vera Ignjatovic Journal: Clin Proteomics Date: 2021-04-14 Impact factor: 3.988